## ICB_Riaz

- **Read Paper:** PMID: [29033130](https://pubmed.ncbi.nlm.nih.gov/29033130)
- **Objective:** Investigates how nivolumab (anti-PD-1) therapy affects tumor evolution in melanoma, focusing on changes in mutation load, immune cell activity, and T-cell responses, providing insights into mechanisms of treatment response and resistance
- **Trial (NCT) ID**: [NCT01621490](https://clinicaltrials.gov/study/NCT01621490)
- **Cancer Type:** Skin Cutaneous Melanoma
- **Data Source:** [BMS038 Analysi](https://github.com/riazn/bms038_analysis) and  [ENA](https://www.ebi.ac.uk/ena/browser/view/PRJNA356761)
